Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02499757 · ClinicalTrials.gov registry record · Phase 1
Does Sweet Taste Potentiate Nicotine Cue Reactivity?
A Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT02499757 is a Phase 1 study that has completed, run by Yale University. The registered enrollment target is 15 participants.
The verdict
NCT02499757, a Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
The investigators' aim is to test the prediction that sweet taste perception enhances the ability of nicotine to induce neural plastic changes in brain reward circuits to increase the saliency, liking and brain reactivity to the sight and vaporized flavor of electronic cigarettes (e-cigarettes).
Interventions
- DEVICE flavor and sweetener
- DEVICE flavor and nicotine
- DEVICE flavor, nicotine and sweetener
- DEVICE flavor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2015-05 |
| Est. Completion | 2015-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02499757
The ClinicalTrials.gov registry entry for NCT02499757 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which flavor and sweetener is the first listed.
NCT02499757 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02499757 about?
NCT02499757 is a clinical study titled "Does Sweet Taste Potentiate Nicotine Cue Reactivity?". The investigators' aim is to test the prediction that sweet taste perception enhances the ability of nicotine to induce neural plastic changes in brain reward circuits to increase the saliency, liking and brain reactivity to the sight and vaporized flavor of electronic cigarettes (e-cigarettes).
What is the current status of trial NCT02499757?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2015-05. Estimated completion is 2015-11.
What interventions are being tested in trial NCT02499757?
The interventions under investigation include: flavor and sweetener (DEVICE), flavor and nicotine (DEVICE), flavor, nicotine and sweetener (DEVICE), flavor (DEVICE).
Who is sponsoring clinical trial NCT02499757?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.